Versa Vascular Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$42M
- Investors
-
6
Versa Vascular General Information
Description
Developer of an implant system designed to treat tricuspid regurgitation by supporting native valve function without disrupting cardiac structures. The company's system offers a steerable catheter for implant placement, device controls for simplified procedures, and an atrial-only implant design, enabling cardiologists to treat a wider range of patients with reduced procedural risk and improved outcomes.
Contact Information
Website
www.versavascular.comCorporate Office
- 2801 Mission Street
- Suite 239
- Santa Cruz, CA 95060
- United States
Corporate Office
- 2801 Mission Street
- Suite 239
- Santa Cruz, CA 95060
- United States
Versa Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 11-Aug-2026 | $42M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | Completed | Stealth | ||||
| 2. Early Stage VC (Series A) | 03-Nov-2021 | $5.55M | $5.55M | Completed | Stealth | |
| 1. Accelerator/Incubator | 01-Jan-2020 | Completed | Stealth |
Versa Vascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C1 | ||||||||
| Series C0 | ||||||||
| Series C2A | ||||||||
| Series B0 | ||||||||
| Series B | ||||||||
| Series A2 | 549,174 | $0.000100 | $1 | $1 | $1 | 1.32% | ||
| Series A1 | 3,050,006 | $0.000100 | $1.64 | $1.64 | $1.64 | 7.3% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Versa Vascular Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Versa Vascular Patents
Versa Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024253721-A1 | System and method for cardiac valve repair | Inactive | 06-Jun-2023 | ||
| EP-4536148-A1 | System and method for cardiac valve repair | Pending | 06-Jun-2022 | ||
| EP-4536148-A4 | System and method for cardiac valve repair | Pending | 06-Jun-2022 | ||
| US-12558222-B2 | System and method for cardiac valve repair | Active | 06-Jun-2022 | ||
| US-20250312157-A1 | System and method for cardiac valve repair | Active | 06-Jun-2022 | A61F2/2454 |
Versa Vascular Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Versa Vascular Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| S3 Ventures | Venture Capital | Minority | ||
| Santa Cruz Ventures | Venture Capital | Minority | ||
| BioStar Capital | Venture Capital | Minority | ||
| Cadence Healthcare Ventures | Venture Capital | Minority | ||
| View Ventures | Venture Capital | Minority |
Versa Vascular FAQs
-
When was Versa Vascular founded?
Versa Vascular was founded in 2020.
-
Where is Versa Vascular headquartered?
Versa Vascular is headquartered in Santa Cruz, CA.
-
What is the size of Versa Vascular?
Versa Vascular has 17 total employees.
-
What industry is Versa Vascular in?
Versa Vascular’s primary industry is Therapeutic Devices.
-
Is Versa Vascular a private or public company?
Versa Vascular is a Private company.
-
What is the current valuation of Versa Vascular?
The current valuation of Versa Vascular is .
-
What is Versa Vascular’s current revenue?
The current revenue for Versa Vascular is .
-
How much funding has Versa Vascular raised over time?
Versa Vascular has raised $64.5M.
-
Who are Versa Vascular’s investors?
S3 Ventures, Santa Cruz Ventures, BioStar Capital, Cadence Healthcare Ventures, and View Ventures are 5 of 6 investors who have invested in Versa Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
